TSVT - 2seventy bio Inc. (TSVT) Q1 2024 Earnings Call Transcript
2024-05-08 15:15:51 ET
2seventy bio, Inc. (TSVT)
Q1 2024 Earnings Conference Call
May 8, 2024, 8:00 AM ET
Company Participants
Jenn Snyder - Senior Vice President, Corporate Affairs
Chip Baird - Chief Executive Officer
Vicki Eatwell - Chief Financial Officer
Anna Truppel-Hartmann - Chief Medical Officer
Conference Call Participants
Rabib Chaudhury - Leerink Partners
Matt Leskowitz - Goldman Sachs
Kelsey Goodwin - Guggenheim Securities
Morgan Gryga - Morgan Stanley
John Newman - Canaccord Genuity
Presentation
Operator
Good day and thank you for standing by. Welcome to the 2seventy bio First Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker’s presentation, there will be a question-and-answer session. [Operator Instructions]
Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your speaker today, Jenn Snyder with 2seventy bio. Please go ahead.
Jenn Snyder
Thank you, Shannon, and good morning, everyone. Thank you for joining us. This morning we issued a press release on our first quarter 2024 financial results. The press release can be found in the Investors and Media section of the company’s website at 2seventybio.com....
2seventy bio, Inc. (TSVT) Q1 2024 Earnings Call Transcript